Biocompatibility of injectable chitosan-phospholipid implant systems.

Injectable biomaterials are desirable therapeutic platforms due to minimal invasiveness and improved patient compliance, and are applicable in such areas as compound delivery and tissue engineering. The present work examined the biocompatibility of injectable blends composed of chitosan, phospholipid and lauric aldehyde (PoLi(gel)-LA) or lauric chloride (PoLi(gel)-LCl). In vitro cytotoxicity was evaluated in L929 and HeLa cell lines. Both blends resulted in acceptable biocompatibility, although greater cell viability was seen with PoLi(gel)-LA. In vivo biocompatibility was investigated in healthy CD-1 mice. Subcutaneous injection of the PoLi(gel)-LA blend caused no local or systemic toxicities over a four-week period while the PoLi(gel)-LCl caused immediate local toxicity. Mice injected intraperitoneally with PoLi(gel)-LA did not show physical or behavioural alterations, and body weight changes did not differ from control animals. Furthermore, histological examination of spleen and liver showed unaltered morphology. Interleukin-6 levels in mice injected with PoLi(gel)-LA did not differ from levels of control animals (6.91+/-3.61 pg/mL versus 6.92+/-5.02 pg/mL, respectively). Biodegradation occurred progressively, with 7.4+/-5.02% of the original injected mass remaining after four weeks. Results obtained herein establish the biocompatibility of PoLi(gel)-LA and indicate its potential for use in various localized therapeutic applications.

[1]  A. U. Daniels,et al.  Six bioabsorbable polymers: in vitro acute toxicity of accumulated degradation products. , 1994, Journal of applied biomaterials : an official journal of the Society for Biomaterials.

[2]  P. Zahedi,et al.  Chitosan-phospholipid blend for sustained and localized delivery of docetaxel to the peritoneal cavity. , 2009, International journal of pharmaceutics.

[3]  James M. Anderson,et al.  Biological Responses to Materials , 2001 .

[4]  P. Satturwar,et al.  Study of the biodegradation and in vivo biocompatibility of novel biomaterials. , 2003, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[5]  A. Mikos,et al.  Injectable biodegradable materials for orthopedic tissue engineering. , 2000, Biomaterials.

[6]  T. Ratliff,et al.  Expression of TNF-related apoptosis-inducing ligand (TRAIL) in megakaryocytes and platelets. , 2004, Experimental hematology.

[7]  M. N. R. Kumar.  A review of chitin and chitosan applications , 2000 .

[8]  Hsing-Wen Sung,et al.  In vivo biocompatibility and degradability of a novel injectable-chitosan-based implant. , 2002, Biomaterials.

[9]  R. Muzzarelli.  Biochemical significance of exogenous chitins and chitosans in animals and patients , 1993 .

[10]  J. Benoit,et al.  Biocompatibility of implantable synthetic polymeric drug carriers: focus on brain biocompatibility. , 2003, Biomaterials.

[11]  Abdel Kareem Azab,et al.  Biocompatibility evaluation of crosslinked chitosan hydrogels after subcutaneous and intraperitoneal implantation in the rat. , 2007, Journal of biomedical materials research. Part A.

[12]  O. Pillai,et al.  Polymers in drug delivery. , 2001, Current opinion in chemical biology.

[13]  B. Kapp,et al.  Histamine release and hypotensive reactions in dogs by solubilizing agents and fatty acids: Analysis of various components in cremophor El and development of a compound with reduced toxicity , 1982, Agents and Actions.

[14]  S. Bhatia,et al.  Correlation of visual in vitro cytotoxicity ratings of biomaterials with quantitative in vitro cell viability measurements , 2008, Cell Biology and Toxicology.

[15]  M D McKee,et al.  Tissue engineering of cartilage using an injectable and adhesive chitosan-based cell-delivery vehicle. , 2005, Osteoarthritis and cartilage.

[16]  M. Cesta.  Normal Structure, Function, and Histology of the Spleen , 2006, Toxicologic pathology.

[17]  A Hatefi,et al.  Biodegradable injectable in situ forming drug delivery systems. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[18]  Robert Langer,et al.  Visual Evidence of Acidic Environment Within Degrading Poly(lactic-co-glycolic acid) (PLGA) Microspheres , 2004, Pharmaceutical Research.

[19]  S. Hudson,et al.  Synthesis and antimicrobial activity of a water-soluble chitosan derivative with a fiber-reactive group. , 2004, Carbohydrate research.

[20]  J C Middleton,et al.  Synthetic biodegradable polymers as orthopedic devices. , 2000, Biomaterials.

[21]  D. Hunkeler,et al.  Rationalizing the design of polymeric biomaterials. , 1999, Trends in biotechnology.

[22]  K. Marra,et al.  Injectable in situ forming biodegradable chitosan-hyaluronic acid based hydrogels for cartilage tissue engineering. , 2009, Biomaterials.

[23]  V. Torchilin.  Recent advances with liposomes as pharmaceutical carriers , 2005, Nature Reviews Drug Discovery.

[24]  C. A. de la Motte,et al.  Platelets trigger a CD40-dependent inflammatory response in the microvasculature of inflammatory bowel disease patients. , 2003, Gastroenterology.

[25]  Y. S. Bakhle,et al.  Host response to sponge implants differs between subcutaneous and intraperitoneal sites in mice. , 2007, Journal of biomedical materials research. Part B, Applied biomaterials.

[26]  V. Dodane,et al.  Pharmaceutical applications of chitosan , 1998 .

[27]  M. Subirade,et al.  In vivo evaluation of whey protein-based biofilms as scaffolds for cutaneous cell cultures and biomedical applications , 2007, Biomedical materials.

[28]  B. Ratner.  Reducing capsular thickness and enhancing angiogenesis around implant drug release systems. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[29]  Tejraj M Aminabhavi,et al.  Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[30]  J. Waniewski,et al.  The Effect of Dialysate Acidity on Peritoneal Solute Transport in the Rat , 1995, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[31]  Micheline Piquette-Miller,et al.  Novel biocompatible intraperitoneal drug delivery system increases tolerability and therapeutic efficacy of paclitaxel in a human ovarian cancer xenograft model , 2007, Cancer Chemotherapy and Pharmacology.

[32]  A. V. von Recum,et al.  Types I and III collagen in the tissue capsules of titanium and stainless-steel implants. , 1997, Journal of biomedical materials research.

[33]  F Moussy,et al.  In vivo evaluation of a dexamethasone/PLGA microsphere system designed to suppress the inflammatory tissue response to implantable medical devices. , 2002, Journal of biomedical materials research.

[34]  T. Standiford,et al.  Elevated levels of macrophage inflammatory protein 2 in severe murine peritonitis increase neutrophil recruitment and mortality , 1997, Infection and immunity.

[35]  C. Schalkwijk,et al.  Improved biocompatibility of bicarbonate/lactate-buffered PDF is not related to pH. , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[36]  Kai-Chiang Yang,et al.  Chitosan/gelatin hydrogel as immunoisolative matrix for injectable bioartificial pancreas , 2008, Xenotransplantation.

[37]  Y. Assaraf,et al.  Potentiation of anticancer-drug cytotoxicity by multidrug-resistance chemosensitizers involves alterations in membrane fluidity leading to increased membrane permeability. , 1995, European journal of biochemistry.

[38]  C. Dass,et al.  Injectable chitosan hydrogels for localised cancer therapy. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[39]  C. Allen,et al.  In vitro and in vivo characterization of a novel biocompatible polymer-lipid implant system for the sustained delivery of paclitaxel. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[40]  C. Allen,et al.  Hybrid films from blends of chitosan and egg phosphatidylcholine for localized delivery of paclitaxel. , 2005, Journal of pharmaceutical sciences.

[41]  K. S. Jones,et al.  Effects of biomaterial-induced inflammation on fibrosis and rejection. , 2008, Seminars in immunology.

[42]  C. Allen,et al.  Impact of intraperitoneal, sustained delivery of paclitaxel on the expression of P-glycoprotein in ovarian tumors. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[43]  J. Cano,et al.  Comparison of three in vitro cytotoxicity assays for estimating surfactant ocular irritation. , 1995, Toxicology in vitro : an international journal published in association with BIBRA.

[44]  C. Allen,et al.  Relationship between composition and properties for stable chitosan films containing lipid microdomains , 2007 .

[45]  Jia-cong Shen,et al.  N,N,N-Trimethylchitosan chloride as a gene vector: synthesis and application. , 2007, Macromolecular bioscience.

[46]  W. Stokes.  Humane endpoints for laboratory animals used in regulatory testing. , 2002, ILAR journal.

[47]  C. Allen,et al.  Synthesis and physicochemical and dynamic mechanical properties of a water-soluble chitosan derivative as a biomaterial. , 2006, Biomacromolecules.

[48]  C. Allen,et al.  Influence of molecular organization and interactions on drug release for an injectable polymer-lipid blend. , 2008, International journal of pharmaceutics.

[49]  C. Allen,et al.  Drug release mechanism of paclitaxel from a chitosan-lipid implant system: effect of swelling, degradation and morphology. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[50]  J. Verweij,et al.  Pharmacological Effects of Formulation Vehicles , 2003, Clinical pharmacokinetics.

[51]  R. Langer,et al.  Biodegradable polymeric microspheres and nanospheres for drug delivery in the peritoneum. , 2006, Journal of biomedical materials research. Part A.

[52]  R. Duncan.  The dawning era of polymer therapeutics , 2003, Nature Reviews Drug Discovery.

[53]  Robert Langer,et al.  Differential degradation rates in vivo and in vitro of biocompatible poly(lactic acid) and poly(glycolic acid) homo- and co-polymers for a polymeric drug-delivery microchip , 2004, Journal of biomaterials science. Polymer edition.

[54]  K. Mäder,et al.  Solid lipid nanoparticles: production, characterization and applications. , 2001, Advanced drug delivery reviews.

[55]  Jong-Chul Park,et al.  Evaluation of the Extraction Method for the Cytotoxicity Testing of Latex Gloves , 2005, Yonsei medical journal.

[56]  A. Corsini,et al.  Quantification of In Vitro Cytotoxicity of Surfactants: Correlation with their Eye Irritation Potential , 1990 .

[57]  R. Robitaille,et al.  Inflammatory response to peritoneal implantation of alginate-poly-L-lysine microcapsules. , 2005, Biomaterials.

[58]  J. Verweij,et al.  Alternative drug formulations of docetaxel: a review. , 2007, Anti-cancer drugs.

[59]  M. Ullman-Cullere,et al.  Body condition scoring: a rapid and accurate method for assessing health status in mice. , 1999, Laboratory animal science.

[60]  N. Sonntag.  The Reactions of Aliphatic Acid Chlorides. , 1953 .

[61]  K. Shimokawa,et al.  Physicochemical properties of structured phosphatidylcholine in drug carrier lipid emulsions for drug delivery systems. , 2008, Colloids and surfaces. B, Biointerfaces.

[62]  A. Yamamoto,et al.  Generic tendency of metal salt cytotoxicity for six cell lines. , 1999, Journal of biomedical materials research.

[63]  R. Panchagnula,et al.  Localized paclitaxel delivery. , 1999, International journal of pharmaceutics.

[64]  S. Perren,et al.  Evaluation of soft tissue reactions at the interface of titanium limited contact dynamic compression plate implants with different surface treatments: an experimental sheep study. , 1996, Biomaterials.

[65]  Scott D. Putney,et al.  Improving protein therapeutics with sustained-release formulations , 1998, Nature Biotechnology.

[66]  D. Mooney,et al.  Hydrogels for tissue engineering. , 2001, Chemical reviews.